A Brief Introduction to Intranasal Medications

Slides:



Advertisements
Similar presentations
INTRA-NASAL DRUG DELIVERY SYSTEM
Advertisements

Intranasal Medications in the Prehospital Setting
Intranasal Medications in clinical practice
Managing Seizure Patients in the Emergency Department Managing Seizure Patients in the Emergency Department James Wheless, MD Director, Texas Comprehensive.
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Preventing Medication Errors in Pediatric and Neonatal Patients
Education and Training Module for Ohio EMS Developed in the 1960s Opioid antagonist Emergent overdose treatment in the hospital and prehospital settings.
2014 EMR Naloxone Presentation DPH/EMS Program Wisconsin Department of Health Services Naloxone Intranasal Administration in the Pre-hospital Setting –
Status Epilepticus-Definition
WREMAC BLS Naloxone In-service
Lecture 4.
Naloxone formulation update
Region 6 Protocol Update 2014 Pharmacology Presence Regional EMS.
Drug Schedules. Goal: to organize the control of drugs under 5 classifications (schedules of controlled substances) Potential for abuse Accepted medical.
Preparing and Administering Medications
Oral Sedation.
IV Flow Rates –BASED ON BODY WEIGHT
First Line Therapy in Acute Seizure Management William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert Wood Johnson University Hospital.
Pediatric Prehospital Seizure Management: Evidence Based Guidelines and State of Care in CO Kathleen Adelgais, MD MPH Pediatric Emergency Medicine Children’s.
Intranasal Medications in the Prehospital Setting.
Intranasal Medications in clinical practice
Benzodiazepines What are the Best Non-IV Parenteral Options for a Seizing Patient? William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert.
2014 Intranasal Pilot DPH/EMS Program Wisconsin Department of Health Services Naloxone Intranasal Administration in the Pre-hospital Setting – Basic Life.
Emergency Management of Seizures
Status epilepticus. Status Epilepticus Traditionally, SE is defined as continuous or repetitive seizure activity persisting for at least 30 minutes without.
Michel J. Sabbagh, M.D., Maunak V. Rana, M.D. Intraoperative Intrasal Opioid Delivery Michel J. Sabbagh, M.D., Maunak V. Rana, M.D. Department of Anesthesiology,
Recommendations on the Management of Opioid Overdose Ruth Birgin.
INTRAVENOUS INFUSION.
Prepared by : Areen Zraikah Dana Fatayer. Pharmacology: Naloxone and nalmefene are pure opioid antagonists that competitively block mu, kappa, and delta.
Part F Blood and fluid exposure Exposure? Injury with sharp object. Contamination of open wound with blood or body fluid. Eye or mucosal splash with.
EMS Intranasal Medications: Prehospital Setting Todd Davis, MD, EMT-B Emergency Medicine University of Cincinnati Cincinnati, OH.
Management. Goals of emergency management for status epilepticus Ensure adequate brain oxygenation and cardiorespiratory function Terminate clinical and.
INJECTABLES Nora A. Alkhudair. Injections Percutaneous introduction of a medicinal substance, fluid or nutrient into the body. (e. g. intradermal, subcutaneous,
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
Copyright restrictions may apply Intranasal Midazolam vs Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients With Epilepsy Holsti.
Bioavailability Dr Mohammad Issa.
Bledsoe et al., Paramedic Care: Principles & Practice, Volume 1: Introduction to Advanced Prehospital Care, 3rd Ed. © 2009 by Pearson Education, Inc. Upper.
Bledsoe et al., Essentials of Paramedic Care: Division 1 © 2006 by Pearson Education, Inc. Upper Saddle River, NJ Division 1 Introduction to Advanced Prehospital.
Pharmacology I BMS 242 Lecture I (Continued) Introduction; Scope of Pharmacology Routes of Drug Administration Dr. Aya M. Serry 2015/2016.
Status epilepticus the paeds emerg perspective Stephen C. Porter MD MPH MSc Division Chief, Pediatric Emergency Medicine The Hospital for Sick Children.
First Line Therapy in Acute Seizure Management: Focusing on the Pediatric Patient William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert.
Drug Dosages and Intravenous Calculations
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
Naloxone: Prescribing and Dispensing
First Responder Naloxone Grant Webinar
Education and Training Module for Ohio EMS – Version 2.0.
Intranasal Drug Deliver – A new way John Mackenzie, June 2010.
Pre-hospital Management P.J. Wynnyk, M.D. Biochemistry of Seizures.
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
AKA. What the Hell are the Medical Directors Doing? Dan O’Donnell Beech Grove Audit and Review 3/11/08.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Intranasal Midazolam vs Rectal Diazepam for the Home.
Unit 3 Lesson 5 General Pharmacology for ALS
Copyright © 2010 American Medical Association. All rights reserved.
Sierra – Sacramento Valley EMS Agency
Presentation On Routes of drug administration & it’s significance
ESETT Eligibility Overview
Introduction; Scope of Pharmacology Routes of Drug Administration
New non-injectable naloxone products: Global overview
Intranasal Medications in the Prehospital Setting
Department of Pharmacy, Texas Children’s Hospital, Houston, TX3
Drug Schedules.
Grays Harbor EMS & Trauma Care Council October 2016
Emergency Management of Seizures
EMT Naloxone Administration
Presentation transcript:

A Brief Introduction to Intranasal Medications Joseph Lewis, M.D. Medical Director, Honolulu EMS 2009

Intranasal Medications in the Prehospital Setting WHY?

The problem! The CDC estimates: 600,000 percutaneous injuries each year involving contaminated sharps.

High Risk Patients in the field! HIV+ patients = 4.1 to 8.3/100 transports Marcus et al, Ann Em Med, 1995 *Hepatitis >10 patients /100 patients High risk environments Altered patients, combative Scene control issues Moving ambulance

Intranasal Medication Administration Intranasal Medication administration offers a truly “Needleless” solution to drug delivery.

Intranasal Medication Administration: Basic Concepts Its easy and convenient because… Almost everyone has a nose No special training is required to deliver the medication No shots are needed It is painless It eliminates any risk of a needle stick to you, the medical provider

Intranasal Medication Administration: Factors Affecting Drug Absorption Volume and concentration: Best: Low volume & High concentration. Too large a volume or too weak a concentration may lead to failure because the drug cannot be absorbed in high enough quantity to be effective. Volumes over 1 ml per nostril are likely too dilute and may result in runoff out of the nostril.

Intranasal Medication Administration: Factors Affecting Drug Absorption Delivery system characteristics: Atomization results in higher bioavailability than either spray or drops. For this reason, nasal drugs must use an atomized drug delivery system.

Intranasal Medication Administration: Factors Affecting Drug Absorption Nasal mucosal characteristics: If there is something wrong with the nasal mucosa it may not absorb medications effectively. Examples: Vasoconstrictors like cocaine prevent absorption. Bloody nose, nasal congestion, mucous discharge all can prevent mucosal contact of drug. Destruction of nasal mucosa from surgery or cocaine abuse – no mucosa to absorb the drug.

Mucosal Atomization Device (MAD) MAD - Mucosal Atomization device: Device designed to allow emergency personnel to delivery nasal medications as an atomized spray. Broad 30-micron spray ensure excellent mucosal coverage.

Nasal Drug Delivery: What Medications? FDA approved: A large number of medications ranging from nasal steroids to antibiotics to opiate anesthetics are FDA approved. Non-FDA approved: Many other medications are effective via the nasal mucosa, but the pharmaceutical companies have not pursued FDA clearance for nasal delivery for a number of financial reasons as opposed to medical reasons.

Nasal Drug Delivery in EMS: What Medications? Drugs of interest to EMS systems: Intranasal naloxone (Narcan) Intranasal midazolam (Versed) Nitroglycerine Others

Intranasal (IN) Naloxone Background Absorption of IN naloxone almost as fast as IV in both animal and human models Hussain et al, Int J Pharm, 1984 Loimer et al, Int J Addict, 1994 Loimer et al, J Psychiatr Res, 1992 “Atomization” of medications show much better absorption via the IN route then IV Thorsson et al, Br J Clin Pharmacol, 1999

The Denver Experience… Denver Health Paramedic System Administering 600-800 doses of naloxone (Narcan®) a year intravenously to patients Sheathed needles were not used properly No change in incidence of bloodborne exposures

Prehospital IN Naloxone Mucosal Atomizer Device (MAD) Single-use Disposable Fits on standard syringe

Mucosal Atomizer Device (MAD) The white plastic you see on this standard 2cc luer lock syringe is the atomizer and it costs about 23 cents.

IN Naloxone by Paramedics

IN Naloxone by Paramedics

Prehospital IN Naloxone Results (cont.). 43/52 (83%) = “IN Naloxone Responders.” Mean time = 3.9 minutes (range 1-11 min.). Median time = 3 min. Mean time from first contact = 9.9 min. Median time from first contact = 8 min. 9/52 (17%) = “IN Non-responders.” 4 patients noted to have “epistaxis,” “trauma,” or “septal abnormality.”

Prehospital IN Naloxone Results (cont.) IN Naloxone Responders 12/43 (29%) got no IV in the field 7/43 (16%) required additional dose of IV naloxone “leakage from L nares” “aroused slowly” “recurrent somulence” “2mg IV given due to slow response” “lower IN dose - spilled filling syringe” “pt responded within 90-120 sec, but still had decr LOC

Prehospital IN Naloxone Take away lessons for nasal naloxone: Dose and volume – higher concentration preferred so use 1mg/ml IV solution. Delivery – immediately on decision to treat inject naloxone into nose with MAD, then begin standard care. Successful awakening eliminates the need for any IV or further ALS care. Awakening is gradual, but adequate respiratory efforts occur as fast or faster than IV naloxone due to no delays with IV start. Not 100% effective so failures with IN naloxone need to be followed with IV naloxone.

Prehospital IN Midazolam Why intranasal midazolam for seizures in the EMS setting? No needles, no need for an IV in a seizing patient. Rapid delivery – No delays in IV attempts. Socially acceptable: No need for rectal drug administration.

IN Midazolam Supporting data: Nasal midazolam has been extensively studied for over a decade with hundreds of studies published regarding its effectiveness for sedating children. Very effective for treating acute seizures and status epilepsy.

IN Midazolam Seizures. Lahat et al, BMJ, 2000. Prospective study: IN midazolam versus IV diazepam for prolonged seizures (>10 minutes) in children. Similar efficacy in stopping seizures (app. 90%). Time to seizure cessation: IV Valium: 8.0 minutes. IN Versed: 6.1 minutes.

IN Midazolam Lahat et al, BMJ, 2000 (cont): Conclusions: IV diazepam and IN midazolam have similar efficacy at controlling prolonged seizures in children. IN midazolam controls seizures more rapidly because there is no delay in establishing an IV.

IN Midazolam Sheepers et al, Seizure, 2000. IN midazolam for treatment of severe epilepsy in adults. Results: IN midazolam effective in 94% of seizures. Conclusion: IN midazolam an effective method for controlling seizures and is a “more acceptable and dignified route” than rectal diazepam.

IN Midazolam Take away lessons for nasal midazolam: Dose and volume: Higher concentration required - use 5mg/ml IV solution. Dosing calculations are difficult: Use a predefined age or weight based table to determine dose. Give max of 1 ml per nostril and 10 mg total. Deliver immediately on decision to treat: Atomize into nose with MAD, then begin standard care. Efficacy: Not quite 100% effective so failures with nasal may need follow-up with IV therapy.

Dosage Charts Midazolam 5mg/ml concentration Dosing chart Total kg wt X 0.2 mg = total mg dose of Midazolam (maximum of 10 ml Patient age (years) Weight (kg) IN Midazolam volume in ml*  Volume        Dose (mg) Neonate 3  kg 0.3 ml             0.6 mg <1  yr 6  kg 0.4 ml             1.2 mg 1  yr 10  kg 0.5ml              2.0 mg 2  yr 14  kg 0.7 ml             2.8 mg 3  yr 16  kg 0.8 ml             3.2 mg 4  yr 18  kg 0.9 ml             3.6 mg 5  yr 20  kg 1.0 ml             4.0 mg 6  yr 22  kg 1.0 ml             4.4 mg 7  yr 24  kg 1.1 ml             4.8 mg 8  yr 26  kg 1.2 ml             5.2 mg 9  yr 28  kg 1.3 ml             5.6 mg 10  yr 30  kg 1.4 ml             6.0 mg 11  yr 32  kg 1.4 ml             6.4 mg 12  yr 34  kg 1.5 ml             6.8 mg Small teenager 40  kg 1.8 ml             8.0 mg Adult or full-grown teenager > 50 kg 2.0 ml            10.0 mg

Example Standing orders IN Medications Hawaii State EMS Midazolam intranasal IN for seizure Dose 0.2 mg/kg IN up to maximum of 10 mg Drug comes 5mg/ml Patient weights 20 kg Calculated Dose 4 mg versed Give 0.8 ml via atomizer in one nare, which is under the maximum of 1 ml per nare.

Example Standing orders IN Medications Hawaii State EMS Midazolam intranasal IN for seizure Dose 0.2 mg/kg IN Drug comes 5mg/ml Patient weights 40 kg Calculated Dose 8 mg versed Give 1.6 ml via atomizer, 0.8 ml in each nare, remembering that the desired upper limit is 1 ml per nostril.

Example Standing orders IN Medications Hawaii State EMS Midazolam intranasal IN for seizure Dose 0.2 mg/kg IN Drug comes 5mg/ml Patient weights 80 kg Calculated Dose 16 mg so give max dose of 10 mg only! Give 2 ml via atomizer, 1 ml in each nare.

Dosage Charts Midazolam 5mg/ml concentration Dosing chart Total kg wt X 0.2 mg = total mg dose of Midazolam (maximum of 10 ml Patient age (years) Weight (kg) IN Midazolam volume in ml*  Volume        Dose (mg) Neonate 3  kg 0.3 ml             0.6 mg <1  yr 6  kg 0.4 ml             1.2 mg 1  yr 10  kg 0.5ml              2.0 mg 2  yr 14  kg 0.7 ml             2.8 mg 3  yr 16  kg 0.8 ml             3.2 mg 4  yr 18  kg 0.9 ml             3.6 mg 5  yr 20  kg 1.0 ml             4.0 mg 6  yr 22  kg 1.0 ml             4.4 mg 7  yr 24  kg 1.1 ml             4.8 mg 8  yr 26  kg 1.2 ml             5.2 mg 9  yr 28  kg 1.3 ml             5.6 mg 10  yr 30  kg 1.4 ml             6.0 mg 11  yr 32  kg 1.4 ml             6.4 mg 12  yr 34  kg 1.5 ml             6.8 mg Small teenager 40  kg 1.8 ml             8.0 mg Adult or full-grown teenager > 50 kg 2.0 ml            10.0 mg